Our ****** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Delivered broad-based growth across all segments, driven by a deliberate enterprise-wide focus on margin recovery and operational discipline.
Aetna's performance reflects the ****** ulative impact of coordinated actions over two years, resulting in over $2 billion of year-over-year improvement in adjusted operating income.
CVS Pharmacy has established itself as the 'best-run national pharmacy' through intentional investments in technology and colleague engagement, leading to consistent script growth and service excellence.
Strategic positioning in the GLP-1 market utilizes a multi-channel approach, capturing volume through funded benefits while expanding direct-to-consumer access via MinuteClinic and manufacturer partnerships.

#pharmacy

Our ******* ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Achieved record first-half profitability with $1 billion in net income, driven by disciplined pricing and a scalable technology platform that expanded operating leverage.
Attributed significant MLR improvement to a strong current-year performance and a market reset compared to the prior year, alongside favorable utilization trends.
Leveraged the proprietary 'Oswell' AI agent to guide 1 in 4 members to high-value care sites, resulting in an average savings of $75 per appointment.
Utilized AI-powered medical economics models to identify pharmacy cost outliers early, expecting these capabilities to generate tens of millions in annual savings.

#savings #utilized #analysts

From buying in bulk to scrutinizing buzzwords on product packaging, TODAY contributor and NewBeauty editor at large, Sarah Eggenberger, shares smart strategies for shopping at the grocery store, pharmacy, and more, that'll save you big bucks.

#eggenberger

Colby Rearick was a home run shy of the cycle in Martella's Pharmacy's 17-1 blowout win over Brooklyn at Sargent Stadium at the Point Wednesday afternoon.
Rearick, who batted ninth in the order, tallied three hits, six total bases and five RBIs in the victory.
Martella's Pharmacy totaled 16 hits, drew seven walks and had as many batters hit by a pitch.
The 2025 tournament runner-up will advance to the knockout bracket, where it has another chance to compete for the club's second AAABA ***** le.
Martella's Pharmacy will face 3-0 New Orleans Thursday. The Boosters have outscored their opponents 26-6 in this year's tournament.

#hits #sargent #wednesday

Cleveland B2Bulls starter Owen Tornow held the high-powered Mainline Pharmacy offense without a hit through four innings Wednesday night at Sargent's Stadium.
But the defending champion Johnstown franchise found its figurative footing in the fifth, scoring six runs – enough for a combination of three effective pitchers – in Mainline Pharmacy's 6-1 victory to clinch Pool C in the 81st AAABA Tournament.
"At the end of the day, sometimes it's ugly, sometimes it's pretty," Mainline Pharmacy manager Chance Osborne said. "We just have to find a way to make it happen."
So far, the Johnstown team has succeeded doing exactly that. Mainline Pharmacy carries a 3-0 record into the elimination quarterfinal round Thursday at the Point against Altoona-1 Imler's Poultry (7 p.m.).
Cleveland (2-1) finished second in Pool C and has a date against Pool D winner Buffalo (3-0) at noon Thursday at Forest Hills Junior-Senior High School field.

#pharmacy #pool #owen

Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, the Fund appreciated 10.61% on an annualized basis, compared with 10.02% for the Benchmark and 14.83% for the Index. Strong stock selection in pharmaceuticals, biotechnology, health care equipment, and life sciences tools and services supported the Fund's outperformance, although limited exposure to managed care stocks reduced relative returns. The Fund remains positive on health care due to improving biotechnology funding, strong acquisition activity, recovering managed care margins, and growth from an aging population, chronic disease, medical innovation, and higher health care spending. In addition, please check the Fund's top five holdings to know the best picks in 2026.
In its second-quarter 2026 investor letter, Baron Health Care Fund highlighted Eli Lilly and Company (NYSE:LLY) as a notable performance contributor. Eli Lilly and Company (NYSE:LLY) discovers, develops, manufactures, and markets human pharmaceutical products in the United States and internationally. On August 03, 2026, Eli Lilly and Company (NYSE:LLY) closed at $1,121.36 per share. The one-month return of Eli Lilly and Company (NYSE:LLY) was -9.24%, and its shares gained 46.40% over the past 52 weeks. Eli Lilly and Company (NYSE:LLY) has a market capitalization of $1.06 trillion.
Baron Health Care Fund stated the following regarding Eli Lilly and Company (NYSE:LLY) in its Q2 2026 investor letter:
"Pharmaceutical company Eli Lilly and Company (NYSE:LLY), currently best known for its diabetes and obesity GLP-1 therapies, contributed to performance as commercial execution and pipeline data reinforced investor confidence in the company's long-term leadership. All three major pharmacy benefit managers now cover Lilly's obesity portfolio, including its new daily oral GLP-1, Foundayo. This marks a reversal from last summer, when CVS Caremark provided preferred coverage for Novo Nordisk's Wegovy and raised concerns about a potential price war. The shift suggests that patients and physicians prefer Zepbound and are driving demand. Clinical trial data further reinforces our view that Lilly has one of the strongest next-generation metabolic pipelines in the industry. Phase 3 data showed retatrutide delivered weight loss in the high-20% range at higher doses and nearly 20% at lower doses, while maintaining excellent tolerability. We are also excited about eloralintide, where Phase 2 data showed Zepbound-like efficacy and tolerability, with combination data expected soon. Long term, we continue to view Lilly's portfolio as the gold standard in a category that we believe can exceed $150 billion."

#Health #investor #letter

Oppenheimer downgraded Walmart stock to a neutral rating, citing reduced outperformance potential.
Analysts highlighted U.S. pharmacy revenue headwinds, valuation concerns, and overly optimistic Street forecasts.
Shares of Walmart started the year strong. Now they've cooled, and some ***** ysts are offering up reasons for further caution.
Oppenheimer ***** ysts on Tuesday downgraded Walmart (WMT) stock to a neutral "perform" rating, withdrawing a $140 per share price target that represented a 26% premium to yesterday's close around $111 and was roughly in line with the Visible Alpha mean.
The ***** ysts cited three reasons they now see a "less compelling outperformance case" for the stock: revenue headwinds facing the U.S. pharmacy business that could hurt same-store sales, a "peakish" valuation, and Wall Street forecasts that they characterized as "well ahead" of the company's guidance.

#walmart #downgraded #outperformance

With a market cap of $30.7 billion, Centene Corporation (CNC) is a leading U.S. healthcare enterprise focused on providing government-sponsored and privately insured health plans. The Missouri-based company operates through Medicaid, Medicare, Commercial, and Other segments, offering a wide range of services including health insurance, specialty care, pharmacy services, and behavioral health support.
Centene has emerged as one of the healthcare sector's standout performers, surging 146.1% over the past year, while the broader S&P 500 Index ($SPX) has gained 21.8%. The rally has shown no signs of slowing, with the stock up 55% year to date, versus the benchmark's 11% advance.
General Motors vs. Ford: 1 Auto Giant Is Winning the EV Race
1 **** anese Company Just Waved a Red Flag for Micron Stock. How to Play It Here.
Billionaire Ken Griffin Just Saved Situational Awareness, But Here's What a Rescue Call From Citadel Really Sounds Like — 'I… Heard the Grim Reaper's Scythe'

#Health #centene #company #medicaid

The company published the arithmetic of its own margin repair, and the first hard proof landed a quarter before the shares started compounding.
CVS Health (CVS) stock has climbed 73% over the past year, from $60.38 to $104.43, against 18.7% for the S&P 500. The group did not move as one: UNH gained 60% and ELV 31%, while CI fell 4.2%. If you watched it run without owning it, the question is not what happened at the top, but what was sitting in the public record before the price responded.
The company puts its fiscal Q1 2026 improvement primarily on Health Care Benefits, the Aetna insurance business. Segment adjusted operating income was about $3 billion on a medical benefit ratio of 85%, against 87% in fiscal Q1 2025, and Aetna contributed over $1 billion of year-over-year improvement. Enterprise adjusted operating income of about $5.2 billion rose more than 12% and adjusted earnings of $2.57 a share rose over 14%, on revenue above $100 billion that grew over 6%. Its two non-insurance segments went the other way, with adjusted operating income down about 7% at Health Services and about 9% at Pharmacy and Consumer Wellness. Full-year 2026 adjusted earnings guidance moved to $7.30 to $7.50 from $7 to $7.20. So the shape of the recovery is clear enough: insurance margin coming back, with the other two segments giving some of it away.
That recovery was no discovery. At its fiscal Q3 2024 results, Health Care Benefits posted an adjusted operating loss of $924 million on a medical benefit ratio of 95%, and management warned the segment might show operating losses for full-year 2024 after earning over $5.5 billion of adjusted operating income in 2023. It then did the arithmetic out loud: restoring Aetna to 2023 profitability was worth well over $3 of embedded adjusted earnings per share. By the fiscal Q4 2024 report it had published the conversion rate too: roughly $0.75 of adjusted earnings per share for each point of Health Care Benefits margin, and about $800 million of segment adjusted operating income for each point of medical cost trend. Medicare Advantage margins had ended 2024 between negative 4.5% and negative 5%, against a 3% to 5% target. That was the promise, and only the promise.
The fiscal Q1 2025 report, the last one public before the run began, is where the swing actually landed: Health Care Benefits adjusted operating income of about $2 billion, up over $1.2 billion from a year earlier, on a medical benefit ratio of 87%, down 310 basis points. Full-year 2025 adjusted earnings guidance went up to $6 to $6.20 from $5.75 to $6, and the company committed to exiting the individual exchange business in 2026, a book then projected to lose $350 million to $400 million across 2025. The base was visibly depressed: revenue over the trailing twelve months was $378.96 billion, up 5.0% year over year, against a three-year average of 8.1%, with net margin at 1.4% against a three-year peak of 2.7%. The evidence was public. Whether it was usable is

JOHNSTOWN, Pa. – Johnstown-2 and Altoona-2 played a baseball game that had a little bit of everything Tuesday.
From superb starting pitching, some shaky defense, a controversial ruling and eventually clutch hitting, the two teams traded blows against one another, but it was Martella's Pharmacy that survived a 6-3 decision over ****** Motors in Pool A action during the early game at Sargent's Stadium at the Point.
The Johnstown-2 squad found itself tied late in the game with the Altoona-2 representative and used some small ball to forge ahead. Two Martella's Pharmacy runners reached base via a hit by pitch, then Jack Messina bunted the two into scoring position.
Johnstown-2 second basemen Mason Pfeil came up and roped a go-ahead single up the middle before center fielder Colby Rearick brought in two valuable insurance runs on a base hit of his own.
"I was definitely looking to be aggressive and I was trying to do damage," said Rearick, the No. 10 batter in the order. "I got a bunch of guys backing me. That's not just me getting a hit, that's everyone on this team and we needed that more than air, so that was a big spot for me to come through."

#altoona #cumming

A catcher-turned-outfielder due to a knee injury, Martella's Pharmacy's Steve Budash appreciates his role in the 81st All American Amateur Baseball **** ociation Tournament perhaps a bit more than most players.
Martella's Pharmacy Roster Page
The Slippery Rock University product from Indiana County underwent a series of knee surgeries that cost him two college seasons and the summer of 2025, which was capped by Martella's Pharmacy's second-place finish in the AAABA Tournament.
"Steve Budash basically had triple knee surgery and was not even sure if he was ever going to be able to come back and play baseball," Martella's Pharmacy manager Kerry Pfeil said.
"He missed all of last summer and all of the past two school years because of the knee surgeries.

#budash

Social Security calculates benefits from your 35 highest-earning years, so a lower-wage job can't reduce a benefit already built on decades of tech salaries.
Claiming at 62 instead of 67 permanently cuts a $3,200 monthly benefit by roughly $960, while waiting until 70 pushes it to nearly $3,970.
Mark's pharmacy-tech paycheck serves as a bridge to delay claiming, while lower taxable income creates room for Roth conversions at reduced tax brackets.
Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.
Seattle's job market is silently rewriting itself. Over the past month, truck-driver postings in the region spiked 231% and security-guard openings jumped 146%, while software-engineer openings suffered the steepest drop, down 56%, according to KUOW reporting on data from the Workforce Development Council of Seattle-King County. Nearly three-quarters of the 7,453 workers laid off in H1 2026 were in the information sector, and Washington state's tech layoffs now rank second highest in the country.

#nearly

Interested in Loblaw Companies Limited? Here are five stocks we like better.
Loblaw delivered solid Q2 growth: Revenue rose 4.1% to C$15.3 billion, adjusted EBITDA increased 5.1% to C$1.9 billion, and adjusted diluted EPS climbed 11.9% to C$0.66.
Discount grocery, pharmacy and e-commerce led momentum. Hard-discount comparable sales grew nearly 4%, drug retail sales increased 6.1%, and online sales rose 19.3%; management also sees significant longer-term growth potential from generic GLP-1 medications.
Management maintained an upbeat outlook and boosted shareholder returns. Loblaw reaffirmed high-single-digit adjusted EPS growth for 2026, raised expected share repurchases to C$2.1 billion, and expects store expansion and distribution-center costs to ease in the second half.
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?

#adjusted #sales

Custom Health Holdings Inc (TSX:CHLT) has signed a binding letter of intent to acquire Wisconsin-based Evergreen Pharmacy LLC in a deal expected to add more than US$78 million in annual revenue to the company.
Under the terms of the letter of intent, Custom Health will pay a total purchase price of US$3.5 million, including at least US$1 million of prescription drug inventory and US$450,000 of net working capital. The purchase price is payable in cash on closing, subject to a US$175,000 indemnity holdback for six months following closing.
The acquisition is expected to strengthen Custom Health's ability to support patients managing complex therapies and expand its operating footprint across the US Midwest.
Shares of Custom Health were up 8.3% in Canada.
Evergreen is licensed to provide pharmacy services in Wisconsin, Illinois and Michigan, with the ability to expand into Minnesota.

#letter

Recent initial public offering Omada Health (OMDA) is the IPO Stock Of The Week following powerful gains over the past few months. Omada stock also sits on Investor's Business Daily's IPO Leaders screen.
The company offers lifestyle support for patients between doctor visits. In early May, the company announced a deal with Eli Lilly (LLY) to add Omada's virtual platform, GLP-1 Care Track, as an option for Lilly's Employer Connect program. This will make it easier for employers covering weight-loss drugs to also add on a membership to the Omada lifestyle support program for their employees.
Omada's GLP-1 Care Track is available through the major pharmacy benefit managers' websites. Employers can also work with Omada directly.
In early May, Omada reported adjusted earnings of 4 cents a share for its first quarter, swinging to a profit from a per-share loss of 16 cents in the year-ago period, according to IBD MarketSurge. Revenue jumped 42% to $78 million.
And for the full year, Wall Street expects the company to earn 26 cents per share, swinging from a per-share loss of 35 cents in 2025. Next year, estimates call for a 62% surge in profit, according to MarketSurge.

JOHNSTOWN, Pa. – Mainline Pharmacy needed extra innings and had to overcome an unusual three-run single by Martella’s Pharmacy Monday night with the Johnstown Collegiate Baseball League regular-season ***** le at stake.
Even though manager Chance Osborne had to watch the final out from the stands, he savored the ending in Mainline Pharmacy’s 5-4 victory over Martella’s Pharmacy in eight innings at Sargent’s Stadium at the Point.
PHOTO GALLERY | Mainline Pharmacy defeats Martella's Pharmacy 5-4 in 8 innings
“Anytime we play Martella’s, we know we’re in for a ballgame and it’s not going to be over until the final out is made,” said Osborne, whose team edged Martella’s Pharmacy 4-3 in the regular-season series to lock down the top spot and secure a berth in the 81st All American Amateur Baseball ***** ociation Tournament next month.
“It means a lot to us to overcome adversity,” he said. “We’ve been on both sides of that. Now, we’ve got to carry that momentum.”

Custom Health Holdings Inc (TSX:CHLT) CEO Shane Bishop talked with Proactive about the company's technology-enabled pharmacy model, its expansion strategy and the opportunities ahead following its recent TSX listing.
Proactive: Welcome back inside our Proactive newsroom. Joining me today is Shane Bishop, CEO of Custom Health. Shane, great to see you.
Shane Bishop: Thank you. I appreciate the invitation and look forward to the conversation.
Custom Health has an interesting history. It was founded to solve challenges in long-term healthcare. Can you explain how the company began?
I'm a pharmacist by profession, and early on we identified a systemic problem between pharmacy and nursing in long-term care around medication administration. We developed technology to improve the accuracy of that process. That original solution remains part of our business today, but it also became the foundation for expanding our model into patients' homes.

Kroger (KR) is the largest pure-play supermarket operator in the United States, founded in 1883 and headquartered in Cincinnati, Ohio. Operating approximately 2,800 stores across more than 20 banners — including Harris Teeter, Fred Meyer, and Ralphs — the company serves millions of U.S. families daily through a diversified retail ecosystem spanning combination food-and-drug stores, multi-department outlets, marketplace stores, and fuel centers.
The company's revenue mix is primarily grocery-led, with a growing digital commerce arm, a robust private-label portfolio, pharmacy services, and Kroger Precision Marketing, helping distinguish it in an increasingly competitive grocery landscape dominated by Walmart (WMT), Costco (COST), and Aldi.
Billionaire Mark Cuban Says He Got Rich And Drunkenly Bought A $125K American Airlines Lifetime Pass —'I Called Them Up And Just Slurred My Words'
AMD Beats NVDA in 1H26 Returns. Here's What's Next for 2H26.
FedEx Is Abandoning Its Supply Chain Business. FDX Stock Investors Need the Logistics Giant to Protect Its Core Network.

McKesson Corporation (NYSE:MCK) is one of billionaire Cliff Asness' top 10 healthcare stock picks. On June 23, McKesson Corporation (NYSE:MCK) issued a recap of its annual McKesson ideaShare 2026 event and stated that it spotlighted AI-powered solutions for independent pharmacies. The conference was held between June 18 and June 21 at the Colorado Convention Center in Denver, and it brought together nearly 5,000 independent community pharmacy professionals from across the US.
Source: Unsplash
McKesson noted that the event centered on helping independent pharmacies navigate a rapidly shifting healthcare landscape. It added that major themes were the integration of artificial intelligence into pharmacy operations, the expansion of patient care services beyond traditional prescription dispensing, and the growing importance of community-based care as a driver of better health outcomes.
For the first time at ideaShare, McKesson hosted a Product Showcase where attendees could evaluate new tools and vote on the solutions they believed would have the greatest impact on their businesses and patients. The company noted that this shift gave pharmacy owners a more direct role in shaping the products and services offered to them.
Meanwhile, on June 2, McKesson closed a strategic investment deal with funds managed by affiliates of Apollo, in which Apollo acquired a minority stake in McKesson's Medical-Surgical Solutions (MMS) business. The transaction had been announced about six weeks earlier, on April 20.

By
Updated July 1, 2026 8:22 am ET
Listen
(1 min)
Kroger KR 3.52%
increase; up pointing triangle
agreed to acquire food and pharmacy retailer Giant Eagle for $1.65 billion in cash and ****** umed liabilities.

STUART, Fla. (AP) — Prosecutors are allowed to review medical records related to Tiger Woods ' March vehicle crash and subsequent arrest in Florida on suspicion of driving under the influence, a judge has ruled.
Judge Darren Steele approved an agreement last week between Woods' defense attorney and the State Attorney's Office that allows prosecutors to request records from Cleveland Clinic Martin South Hospital, where Woods was taken following the March 27 crash. The case is being tried in Martin County circuit court, just north of Palm Beach County.
The judge signed off on a similar agreement in May that grants prosecutors access to all prescription medication records for the legendary golfer at a Palm Beach pharmacy from the start of the year through the end of March. For both hospital and prescription records, prosecutors have agreed to defense attorney Doug Duncan's request for a protective order limiting the release of records only to prosecutors, law enforcement officers, state experts and Woods' defense team.
Woods has pleaded not guilty to driving under the influence. A sheriff’s office report said deputies found two pain pills in his pocket, and he showed signs of impairment after his SUV clipped a truck's trailer and rolled onto its side.
Woods was traveling at high speeds on a beachside, residential road on Jupiter Island with a 30 mph (nearly 50 kph) speed limit when his Land Rover caused $5,000 in damage to the truck, according to an incident report. Woods agreed to a Breathalyzer test that showed no signs of alcohol, but refused a urine test, authorities said.

The Kroger Co. (NYSE:KR) is one of the best stocks to buy now for good returns. On June 22, Morgan Stanley reiterated an Equal Weight rating on the stock but cut the price target to $67 from $73 a share. The Kroger Co. (NYSE:KR) is currently trading at $58 a share.
The investment bank terms the strategy of self-funding price investments to drive market share as prudent, given CEO Greg Foran's track record of supporting execution. However, Morgan Stanley insists that a self-funding price investment strategy comes with its degree of difficulty.
Similarly, on June 22, UBS reiterated a Neutral rating on the stock and cut the price target to $63 from $70. According to UBS, the first-quarter results showed that Kroger Co. has the right plan to strengthen its competitive edge. For starters, the company is well-positioned to fund necessary investments from its savings.
However, the research firm cut its price target amid concerns that Kroger may not have what it takes to deliver long-term targets of 3% to 5% operating income growth and high-digit to low-double-digit shareholder returns.
The Kroger Co. (NYSE:KR) is one of the world's largest food retailers, operating nearly 2,800 grocery stores and multi-department stores across 35 U.S. states. The company serves over 11 million customers daily, offering a massive footprint in grocery, pharmacy, manufacturing, and fuel services.

Serve Robotics Inc (NASDAQ:SERV) is one of the best AI stocks under $10 to buy now. While Serve Robotics shares are down roughly 45% year-to-date, ******* ysts see the pullback as a buying opportunity as they expect the stock to surge more than 190% over the next 12 months. Some 14 hedge funds have stakes in Serve Robotics stock.
alex-knight-2EJCSULRwC8-unsplash
On June 2, Serve Robotics Inc (NASDAQ:SERV) announced a deal to expand its AI-powered robot delivery service beyond the food industry. The company said that NoScrubs will use its sidewalk autonomous robots to deliver laundry orders. NoScrubs offers laundry services across seven major metros. It picks up clothes from customers, then washes, dries, folds, and sends them back.
Serve Robotics operates a fleet of roughly 2,000 robots across the US, and it primarily delivers restaurant meals. It will fulfill NoScrubs laundry orders along with food deliveries in shared markets. This will involve picking up clothes and returning them after the laundry service. According to Serve Robotics, laundry pickup and returns usually happen outside food delivery peak hours.
NoScrubs will ******* ign orders to Serve based on availability and storage needs. Serve Robotics considers laundry delivery as another expansion vertical. It also sees opportunities in grocery, pharmacy, retail, and dry cleaning markets.

A major grocery chain operator has agreed to pay a multimillion-dollar settlement after coming under scrutiny for pricing practices tied to one of its business segments.
The case centers not on what shoppers paid at checkout, but on allegations involving how certain prices were reported behind the scenes.
Federal officials say prescription price reporting practices caused government health care programs to pay more than they should have, resulting in a settlement worth tens of millions of dollars.
The case highlights how prescription pricing disclosures can affect taxpayer-funded health care spending, even when consumers receive discounted pharmacy prices.
Ahold Delhaize USA (ADRNY) has agreed to pay $40 million to resolve allegations that it submitted inflated prescription drug pricing data to federal health care programs, according to the U.S. Department of Justice (DOJ).

Walmart Inc. (NASDAQ:WMT) is one of the best e-commerce stocks to buy as global sales hit records. The company's online retail story is no longer limited to U.S. pickup and delivery, as Walmart is now pushing its marketplace ***** ortment across borders. On June 11, Walmart opened Walmart.com to customers in Mexico, giving them access to hundreds of thousands of eligible items across categories including apparel, home, electronics, and more. The company said that duties, taxes, and fees are shown at checkout and that it plans to expand international shipping to additional markets in the future.
Walmart is also leaning into faster fulfillment as a core e-commerce advantage. On May 28, the company said 30-minute-or-less delivery was available across 33 U.S. markets, covering more than 100,000 eligible items, including groceries, pharmacy products, household supplies, pet food, electronics, and prescriptions. In the first quarter of fiscal 2027, Walmart said global eCommerce grew 26%, Walmart U.S. eCommerce grew 26%, and Walmart International eCommerce grew 27%. Store-fulfilled delivery has more than doubled over the past two years, with more than 36% of those U.S. orders delivered in under three hours during the quarter.
Pixabay/Public Domain
Walmart Inc. (NASDAQ:WMT) is a tech-powered omnichannel retailer serving customers through stores, clubs, e-commerce websites, and mobile apps.
While we acknowledge the potential of WMT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Costco Wholesale Corporation (NASDAQ:COST) is included among the 10 No-Brainer Dividend Stocks to Buy.
Niloo / Shutterstock.com
On June 1, DA Davidson maintained its Neutral rating on Costco Wholesale Corporation (NASDAQ:COST). It also set a $1,000 price target on the stock. At the same time, the firm added the stock to its “Best-of-Breed Bison List,” a group of companies it believes offer strong business opportunities, durable competitive advantages, solid financial performance, and attractive risk-reward profiles.
According to the **** yst, Costco has positioned itself as a destination where consumers can stock up on goods every few weeks. The company stands out through its high-quality private-label products, a well-balanced general merchandise selection, and additional businesses such as pharmacy, optical, and gas services that help bring customers into its warehouses.
The **** yst also noted that Costco’s warehouse model has one of the strongest competitive advantages in retail. The business benefits from low prices, efficient distribution, and a relatively limited number of SKUs, creating significant barriers to entry for competitors. Membership fee income further supports the model and adds another layer of stability to the business.

Iowa pharmacy owners say law regarding benefit managers will keep rural pharmacies in business | Click on the image to read the full story

Iowa pharmacy owners say law regarding benefit managers will keep rural pharmacies in business | Click on the image to read the full story